Black survivors of multiple myeloma say the latest developments in treatment give them hope even as federal research cuts ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved ...

Bone marrow aspirate concentrate (BMAC) is a common treatment for joint injuries. The invasive therapy involves extracting ...

The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

Fifteen-year-old Isabella Harris has a lot going for her. She’s a talented dancer and a dedicated student, but right now ...

Cancer thrives by hijacking the body's own basic survival systems, making it hard to attack tumors without collateral damage ...

Ali Waldon thought the hip pain was just another injury. She was a Division I volleyball player at Mercer University, ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...